Pacific Edge Limited (NZX/ASX: PEB) has announced a commercial agreement with Northern Health, a major provider of healthcare and hospital services in Melbourne’s outer northern suburbs.
Northern Health will use Pacific Edge’s Cxbladder suite of non-invasive diagnostic tests to help manage patients with bladder cancer.
The tests will be used to identify those patients who can safely forego or defer a flexible cystoscopy at their next scheduled hospital visit and further expedite the diagnosis of bladder cancer.
Samples will be collected and sent to Pacific Edge’s CLIA approved and IANZ-accredited laboratory in Dunedin, New Zealand.
This is the first in-market validation of Cxbladder’s clinical utility in a large healthcare network in Australia.
See more
